|
1
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical Characteristics
of Coronavirus Disease 2019 in China. N Engl J Med.
382:1,708–1,720. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T,
Fan YP, Fang C, Huang D, Huang LQ, Huang Q, et al: A rapid advice
guideline for the diagnosis and treatment of 2019 novel coronavirus
(2019-nCoV) infected pneumonia (standard version). Mil Med Res.
7(4)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
WHO: Coronavirus disease 2019 (COVID-19)
Situation Report. urihttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/simplehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
Updated September 28, 2020.
|
|
5
|
Zhang J, Wu S and Xu L: Asymptomatic
carriers of COVID-19 as a concern for disease prevention and
control: More testing, more follow-up. Biosci Trends. 14:206–208.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
China NHCtPsRo: The latest updates on
COVID-19 outbreaks as of 24:00 on September 29. urihttp://www.nhc.gov.cn/xcs/yqtb/202009/9015bdbd354147919d82bd84a68cd919.shtmlsimplehttp://www.nhc.gov.cn/xcs/yqtb/202009/9015bdbd354147919d82bd84a68cd919.shtml.
Updated September 29, 2020.
|
|
7
|
Qiu J: Covert coronavirus infections could
be seeding new outbreaks. Nature:Mar. 20, 2020 (Epub ahead of
print). doi: 10.1038/d41586-020-00822-x.
|
|
8
|
Al-Sadeq DW and Nasrallah GK: The
incidence of the novel coronavirus SARS-CoV-2 among asymptomatic
patients: A systematic review. Int J Infect Dis. 98:372–380.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu Z, Chu R, Gong L, Su B and Wu J: The
assessment of transmission efficiency and latent infection period
in asymptomatic carriers of SARS-CoV-2 infection. Int J Infect Dis.
99:325–327. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X,
Ma H, Chen W, Lin Y, Zheng Y, et al: Clinical characteristics of 24
asymptomatic infections with COVID-19 screened among close contacts
in Nanjing, China. Sci China Life Sci. 63:706–711. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang Y, Liu Y, Liu L, Wang X, Luo N and Li
L: Clinical Outcomes in 55 patients with severe acute respiratory
syndrome coronavirus 2 Who Were asymptomatic at hospital admission
in shenzhen, China. J Infect Dis. 221:1,770–1,774. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rawat M, Chandrasekharan P, Hicar MD and
Lakshminrusimha S: COVID-19 in newborns and infants-low risk of
severe disease: Silver Lining or Dark Cloud? Am J Perinatol.
37:845–849. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qiu H, Wu J, Hong L, Luo Y, Song Q and
Chen D: Clinical and epidemiological features of 36 children with
coronavirus disease 2019 (COVID-19) in Zhejiang, China: An
observational cohort study. Lancet Infect Dis. 20:689–696.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tan F, Wang K, Liu J, Liu D, Luo J and
Zhou R: Viral Transmission and Clinical Features in Asymptomatic
Carriers of SARS-CoV-2 in Wuhan, China. Front Med (Lausanne).
7(547)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tai W, He L, Zhang X, Pu J, Voronin D,
Jiang S, Zhou Y and Du L: Characterization of the receptor-binding
domain (RBD) of 2019 novel coronavirus: Implication for development
of RBD protein as a viral attachment inhibitor and vaccine. Cell
Mol Immunol. 17:613–620. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bunyavanich S, Do A and Vicencio A: Nasal
gene expression of angiotensin-converting enzyme 2 in children and
adults. JAMA. 23:2427–2429. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Do LAH, Anderson J, Mulholland EK and
Licciardi PV: Can data from paediatric cohorts solve the COVID-19
puzzle? PLoS Pathog. 16(e1008798)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu F, Wang A, Liu M, Wang Q, Chen J, Xia
S, Ling Y, Zhang Y, Xun J, Lu L, et al: Neutralizing antibody
responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and
their implications. medRxiv: Apr. 20, 2020 (Epub ahead of print).
doi: urihttps://doi.org/10.1101/2020.03.30.20047365simplehttps://doi.org/10.1101/2020.03.30.20047365.
|
|
19
|
Casadevall A and Pirofski LA: The
convalescent sera option for containing COVID-19. J Clin Invest.
130:1545–1548. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Arteaga-Livias K, Pecho-Silva S,
Panduro-Correa V and Rodríguez-Morales AJ: The dilemmas of the
classification of SARS-CoV-2 infection without clinical
manifestations: Asymptomatic or presymptomatic. J Formos Med Assoc.
119:1237–1238. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang X, Fang J, Zhu Y, Chen L, Ding F,
Zhou R, Ge L, Wang F, Chen Q, Zhang Y and Zhao Q: Clinical
characteristics of non-critically ill patients with novel
coronavirus infection (COVID-19) in a Fangcang Hospital. Clin
Microbiol Infect. 26:1,063–1,068. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhou X, Li Y, Li T and Zhang W: Follow-up
of asymptomatic patients with SARS-CoV-2 infection. Clin Microbiol
Infect. 26:957–959. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ma Y, Xu QN, Wang FL, Ma XM, Wang XY,
Zhang XG and Zhang ZF: Characteristics of asymptomatic patients
with SARS-CoV-2 infection in Jinan, China. Microbes Infect.
22:212–217. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Epidemiology Working Group for NCIP
Epidemic Response, Chinese Center for Disease Control and
Prevention. The epidemiological characteristics of an outbreak of
2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu
Xing Bing Xue Za Zhi. 41:145–151. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
25
|
Nishiura H, Kobayashi T, Miyama T, Suzuki
A, Jung SM, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR
and Linton NM: Estimation of the asymptomatic qratio of novel
coronavirus infections (COVID-19). Int J Infect Dis. 94:154–155.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mizumoto K, Kagaya K, Zarebski A and
Chowell G: Estimating the asymptomatic proportion of coronavirus
disease 2019 (COVID-19) cases on board the Diamond Princess cruise
ship, Yokohama, Japan, 2020. Euro Surveill.
25(2000180)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu Q, Xing Y, Shi L, Li W, Gao Y, Pan S,
Wang Y, Wang W and Xing Q: Coinfection and other clinical
characteristics of COVID-19 in children. Pediatrics.
146(e20200961)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhao D, Wang M, Wang M, Zhao Y, Zheng Z,
Li X, Zhang Y, Wang T, Zeng S, Hu W, et al: Asymptomatic infection
by SARS-CoV-2 in healthcare workers: A study in a large teaching
hospital in Wuhan, China. Int J Infect Dis. 99:219–225.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Meng H, Xiong R, He R, Lin W, Hao B, Zhang
L, Lu Z, Shen X, Fan T, Jiang W, et al: CT imaging and clinical
course of asymptomatic cases with COVID-19 pneumonia at admission
in Wuhan, China. J Infect. 81:e33–e39. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yu X and Yang R: COVID-19 transmission
through asymptomatic carriers is a challenge to containment.
Influenza Other Respir Viruses. 14:474–475. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yan S, Chen H, Xie RM, Guan CS, Xue M, Lv
ZB, Wei LG, Bai Y and Chen BD: Chest CT evaluation of 11 persistent
asymptomatic patients with SARS-CoV-2 infection. Jpn J Infect Dis:
Jun 30, 2020 (Epub ahead of print). doi:
10.7883/yoken.JJID.2020.264.
|
|
32
|
Ali RMM and Ghonimy MBI: Radiological
findings spectrum of asymptomatic coronavirus (COVID-19) patients.
Egypt J Radiol Nucl Med. 51(156)2020.
|
|
33
|
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen
L and Wang M: Presumed Asymptomatic Carrier Transmission of
COVID-19. JAMA. 323:1406–1407. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yu X, Ran D, Wang J, Qin Y, Liu R, Shi X,
Wang Y, Xie C, Jiang J and Zhou J: Unclear but present danger: An
asymptomatic SARS-CoV-2 carrier. Genes Dis: Jul 23, 2020 (Epub
ahead of print). doi: 10.1016/j.gendis.2020.07.010.
|
|
35
|
Zou L, Ruan F, Huang M, Liang L, Huang H,
Hong Z, Yu J, Kang M, Song Y, Xia J, et al: SARS-CoV-2 viral load
in upper respiratory specimens of infected patients. N Engl J Med.
382:1177–1179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen Y, Wang AH, Yi B, Ding KQ, Wang HB,
Wang JM, Shi HB, Wang SJ and Xu GZ: Epidemiological characteristics
of infection in COVID-19 close contacts in Ningbo city. Zhonghua
Liu Xing Bing Xue Za Zhi. 41:667–671. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
37
|
Yin G and Jin H: Comparison of
transmissibility of coronavirus between symptomatic and
asymptomatic patients: Reanalysis of the ningbo COVID-19 Data. JMIR
Public Health Surveill. 6(e19464)2020.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Kim SE, Jeong HS, Yu Y, Shin SU, Kim S, Oh
TH, Kim UJ, Kang SJ, Jang HC, Jung SI and Park KH: Viral kinetics
of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients.
Int J Infect Dis. 95:441–443. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen F, Fu D, Yang Q, Geng Z, Xia J, Wang
Z and Wang L: Low transmission risk of 9 asymptomatic carriers
tested positive for both SARS-CoV-2 nucleic acid and serum IgG. J
Infect. 81:452–482. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Byambasuren O, Cardona M, Bell K, Clark J,
McLaws ML and Glasziou P: Estimating the extent of asymptomatic
COVID-19 and its potential for community transmission: Systematic
review and meta-analysis. medRxiv: Sep 23, 2020 (Epub ahead of
print). doi: urihttps://doi.org/10.1101/2020.05.10.20097543simplehttps://doi.org/10.1101/2020.05.10.20097543.
|
|
41
|
Long QX, Tang XJ, Shi QL, Li Q, Deng HJ,
Yuan J, Hu JL, Xu W, Zhang Y, Lv FJ, et al: Clinical and
immunological assessment of asymptomatic SARS-CoV-2 infections. Nat
Med. 26:1200–1204. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pan Y, Yu X, Du X, Li Q, Li X, Qin T, Wang
M, Jiang M, Li J, Li W, et al: Epidemiological and clinical
characteristics of 26 asymptomatic severe acute respiratory
syndrome coronavirus 2 carriers. J Infect Dis. 221:1,940–1,947.
2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lu S, Lin J, Zhang Z, Xiao L, Jiang Z,
Chen J, Hu C and Luo S: Alert for non-respiratory symptoms of
coronavirus disease 2019 patients in epidemic period: A case report
of familial cluster with three asymptomatic COVID-19 patients. J
Med Virol: Mar 19, 2020 (Epub ahead of print). doi: urihttps://doi.org/10.1002/jmv.25776simplehttps://doi.org/10.1002/jmv.25776.
|
|
44
|
Yang Y, Yang M, Shen C, Wang F, Yuan J, Li
J, Zhang M, Wang Z, Xing L, Wei J, et al: Evaluating the accuracy
of different respiratory specimens in the laboratory diagnosis and
monitoring the viral shedding of 2019-nCoV infections. medRxiv:
doi: urihttps://doi.org/10.1101/2020.02.11.20021493simplehttps://doi.org/10.1101/2020.02.11.20021493.
|
|
45
|
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su
Y, Wang X, Yuan J, Li T, Li J, et al: Antibody responses to
SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin
Infect Dis. 71:2027–2034. 2020.PubMed/NCBI View Article : Google Scholar
|
